Researchers at Western University and Lawson Health Research Institute are using tobacco plants as ‘green bioreactors’ to produce an anti-inflammatory protein with powerful therapeutic potential.
The plants are being used to produce large quantities of a human protein called Interleukin 37, or IL-37. The protein is naturally produced in the human kidney in very small quantities and has powerful anti-inflammatory and immune-suppressing properties, providing potential for treating a number of inflammatory and autoimmune disorders like type 2 diabetes, stroke, dementia and arthritis.
“This protein is a master regulator of inflammation in the body, and has been shown in pre-clinical models to be effective in treating a whole host of diseases,” said Dr. Tony Jevnikar, Professor at Western’s Schulich School of Medicine & Dentistry and Scientist at Lawson. “The human kidney produces IL-37, but not nearly enough to get us out of an inflammation injury.”
And while showing promise in animal models, IL-37’s use clinically has been limited because of the inability to produce it in large quantities at a price that is feasible clinically. Currently, it can be made in very small amounts using the bacteria E. coli, but at a very high cost.
That’s where the tobacco plants come in.
This work is the first of its kind to demonstrate that this functional human protein can be produced in plant cells. “The plants offer the potential to produce pharmaceuticals in a way that is much more affordable than current methods,” said Shengwu Ma, PhD, Adjunct Professor in the Department of Biology at Western and Scientist at Lawson. “Tobacco is high-yield, and we can temporarily transform the plant so that we can begin making the protein of interest within two weeks.”
The researchers have shown in a recent study published in the journal Plant Cell Reports, that the protein can be extracted and quantified from the plant cells in a way that maintains its function. Now that they’ve shown they can produce the protein in tobacco, it can be translated to other plants, like potatoes.
Dr. Jevnikar is investigating the effect that IL-37 has for preventing organ injury during transplantation. When an organ is removed for transplantation and then transferred to a recipient, inflammation occurs when the blood flow is restored to the organ. He and his team believe IL-37 provides a way to prevent that injury.
“I hope that this work will impact a change in how people view plants and hopefully this approach will be a way to provide treatments to patients that are effective and affordable,” Dr. Jevnikar said.
The Latest on: Green bioreactors
via Google News
The Latest on: Green bioreactors
- Algae’s energy potential bloomson May 1, 2021 at 5:00 pm
The project is unmistakably green, a shade that can be produced ... only a few in the world to include functioning, pilot-scale bioreactors connected to a municipal wastewater treatment plant.
- Bioreactors Market Projections 2027 | Merck Group, Cytiva, Getinge, Eppendorf AG, Sartorius Group and Thermo Fisher Scientificon April 28, 2021 at 4:57 am
The bioreactors market is expected to expand on the back of rising requirement for improved pharmaceuticals, vaccines, and antibodies worldwide. The COVID-19 pandemic has impacted millions of ...
- The Importance of Hybrid-capture Technology to Recognize and Characterize Viral Threatson April 23, 2021 at 3:30 pm
Dr. Rebecca Nugent joined Twist Bioscience in 2015 after spending many years in the biofuels and green chemicals industry. Dr. Nugent has held many roles within Twist and is currently the Sr. Director ...
- Getinge's (GNGBF) CEO Mattias Perjos on Q1 2021 Results - Earnings Call Transcripton April 19, 2021 at 9:00 pm
When it came to Sterile Transfer products and bioreactors, these are the categories ... whether there’s some green shoots there? Or is that still somewhat hindered as a market?
- How the humble woodchip is cleaning up water worldwideon April 15, 2021 at 12:10 pm
But there’s a simple solution that significantly reduces the amount of nitrogen in drainage water, regardless of the production system or location: denitrifying bioreactors. “Nitrogen pollution from ...
- Tucson Tech: UA tech spinoff aims to make algae for nutraceuticalson April 9, 2021 at 11:05 am
Bioreactors are commonly used for growing organisms ... to grow algae to produce spirulina — a cyanobacteria, or blue-green algae, used as a food supplement — and other algae that produce ...
- The Hidden Story Behind Tampa’s Toxic Poolon April 9, 2021 at 6:06 am
The Green Revolution literally applied the machinery ... The company is setting up its bioreactors across the Midwest, taking in local organic waste, and converting it to a soil amendment to ...
- Algae Automationon April 8, 2021 at 5:00 pm
You could call it the great green hope of the environmental movement ... OriginOil grows algae in a bioreactor. Bioreactors have an advantage over Mother Nature in that they can stimulate growth ...
- Government of Canada announces over $5M in clean tech funding for British Columbia Fisheries and Aquaculture Projectson April 7, 2021 at 2:06 pm
The Fisheries and Aquaculture Clean Technologies Adoption Program is a federal initiative encouraging the adoption of green technologies in the fishing ... BC to purchase and install algae bioreactors ...
- Outlook on the Single-Use Bioreactors Global Market to 2030 - Featuring Cytiva, Merck Millipore & Pall Among Otherson April 6, 2021 at 10:33 am
12.5. Global Single-Use Bioreactors Market: Distribution by Type of Cell Culture 12.6. Global Single-Use Bioreactors Market: Distribution by Type of Molecule 12.7. Global Single-Use Bioreactors ...
via Bing News